Download PDF
CC BY-NC-ND 4.0 · Eur J Dent 2009; 03(04): 257-266
DOI: 10.1055/s-0039-1697442
Original Article
Dental Investigation Society

A New Form of Intraoral Delivery of Antifungal Drugs for the Treatment of Denture-Induced Oral Candidosis

Wala M. Amin
a   Professor of Prosthodontics and Biomaterials, Dept. of Prosthetic Dentistry, Faculty of Dentistry, University of Jordan, Jordan
,
Muna H. Al-Ali
b   Teaching assistant and clinical instructor, Faculty of Dentistry, University of Jordan, Jordan
,
Nesreen A. Salim
b   Teaching assistant and clinical instructor, Faculty of Dentistry, University of Jordan, Jordan
,
Sandra K. Al-Tarawneh
b   Teaching assistant and clinical instructor, Faculty of Dentistry, University of Jordan, Jordan
› Author Affiliations
Further Information

Publication History

Publication Date:
27 September 2019 (online)

  PDF Download Permissions and Reprints

ABSTRACT

Objectives: To monitor the release of the antifungal drugs Fluconazole, Chlorhexidine and a combination of the two from an auto-polymerized poly (methyl methacrylate) (PMMA) denture base resin; and to investigate the effect of the released drugs upon the growth of Candida albicans.

Methods: A high performance liquid chromatography-Ultra violet (HPLC-UV) method was used in the analysis of the released drugs into distilled water from PMMA discs doped with the antifungal drugs Fluconazole (10%), Chlorhexidine (10%) and a combination of the two drugs (5% each). The antifungal efficacy of the released drugs was monitored, microbiologically, employing “well” technique on a Saborauds culture medium inoculated with a resistant strain of Candida albicans.

Results: It was shown that Fluconazole, Chlorhexidine and the combination of the two drugs can be successfully incorporated with PMMA. It was found that the drugs leach steadily out of the PMMA resin into distilled water at mouth temperature and that sustained drug release continued throughout the 28 days test period. It was also shown that the released drugs demonstrated an antifungal activity against the resistant Candida albicans and this was most remarkable in the combined drugs samples.

Conclusions: The findings of this investigation have a clinical value in terms of their significant contribution to the treatment of fungal infections of the oral cavity. The sustained release of antifungal drugs from the PMMA resin clearly constitutes a new dosage form of these drugs via the poly (methyl methacrylate) delivery system. (Eur J Dent 2009;3:257-266)

Key words:

Fluconazole - Chlorhexidine - Synergism - Auto-polymerized PMMA - Eluates - Antifungal drug - HPLC-UV - Denture stomatitis - Candida albicans
 

  • REFERENCES

  • 1 Budtz-Jørgensen E. The significance of Candida albicans in denture stomatitis. Scand J Dent Res 1974;82:5-51.
  • 2 Budtz-Jørgensen E, Theilade E, Theilade J. Regional variations in viable bacterial and yeast counts of 1-week-old denture plaque in denture stomatitis. Scand J Dent Res 1983;91:288-295.
  • 3 Pollack B, Buck IF, Kalnius J. An oral syndrome complicating pschopharmacotherapy: study II. Am J Psychiatry 1964;121:384-386.
  • 4 Budtz-Jørgensen E, Theilade E, Theilade J. Quantitative relationship between yeasts and bacteria in denture-induced stomatitis. Scand J Dent Res 1983;91:134-142.
  • 5 Bergendal T, Holmberg K, Nord CE. Yeast colonization in the oral cavity and feces in patients with denture stomatitis. Acta Odontol Scand 1979;37:37-45.
  • 6 Brook IM, van Noort R. Controlled delivery of drugs. Br Dent J 1984;157:11-15.
  • 7 Garcia CR, Siquerios A, Benet LZ. Oral controlled release preparations. Pharm Acta Helv 1978;53:99-109.
  • 8 Paul DR. Polymers in controlled release technology. American Chemical Society Symp. 1976; Series No. 33 Controlled release polymeric formulations, 1-3.
  • 9 Budtz-Jorgensen E, Lombardi T. Antifungal therapy in the oral cavity. Periodontol 2000 1996;10:89-106.
  • 10 Dar-Odeh NS, Shehabi AA. Oral candidosis in patients with removable dentures. Mycoses 2003;46: 187-191.
  • 11 White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998;11:382-402.
  • 12 Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 1995;35:103-114.
  • 13 Epstein JB. Antifungal therapy in oropharyngeal mycotic infections. Oral Surg Oral Med Oral Pathol 1990;69:32-41.
  • 14 Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000;1 1:172-198.
  • 15 Samaranayake LP, McCourtie J, MacFarlane TW. Factors affecting the in-vitro adherence of Candida albicans to acrylic surfaces. Arch Oral Biol 1980;25:611-615.
  • 16 Budtz-Jorgensen E, Carlino P. A miconazole lacquer in the treatment of Candida-associated denture stomatitis. Mycoses 1994;37:131-135.
  • 17 Nikawa H, Yamamoto T, Hamada T, Rahardjo MB, Murata H, Nakanoda S. Antifungal effect of zeolite-incorporated tissue conditioner against Candida albicans growth and/or acid production. J OralRehabil 1997;24:350-357.
  • 18 Douglas WH. Dental materials as carriers for therapy. Dent Update 1977;4:395.
  • 19 Douglas WH, Walker DM. Nystatin in denture liners-an alternative treatment of denture stomatitis. Br Dent J 1973;135:55-59.
  • 20 Schneid TR. An in vitro analysis of a sustained release system for the treatment of denture stomatitis. Spec Care Dentist 1992;12:245-250.
  • 21 Addy M. In vitro studies into the use of denture base and soft liner materials as carriers for drugs in the mouth. J Oral Rehabil 1981;8:131-142.
  • 22 Addy M, Handley R. The effects of the incorporation of chlorhexidine acetate on some physical properties of polymerized and plasticized acrylics. J Oral Rehabil 1981;8:155-163.
  • 23 Garcia CR, Siqueiros A, Benet LZ. Oral controlled release preparations. Pharm Acta Helv 1978;53: 99-109.
  • 24 Mirth DB, Bartkiewicz A, Shern RJ, Little WA. Development and in vitro evaluation of an intra-oral controlled-release delivery system for chlorhexidine. J Dent Res 1989;68:1285- 1288.
  • 25 Riggs PD, Braden M, Patel M. Chlorhexidine release from room temperature polymerising methacrylate systems. Biomaterials 2000;21:345-351.
  • 26 Patel MP, Cruchley AT, Coleman DC, Swai H, Braden M, Williams DM. A polymeric system for the intra-oral delivery of an anti-fungal agent. Biomaterials 2001;22:2319- 2324.
  • 27 Braithwaite A, Smith FJ. Chromatographic methods. London. Blackie Academic and Professional. 1996